Strategy
early-stage techpre-IPO
Description
No detailed brain note yet for The Bleeding Edge. USPs will populate as FID mines its promos.
Promos (0)
No analyzed promos yet.
Recent Emails
View all (94) in iSpy →- Read full email2026-10-30EDITORIALThe Bleeding EdgeAI Is a Double-Edged SwordJeff Brown provides market commentary on institutional volatility around AI infrastructure spending, analyzing why Alphabet, Amazon, and Meta are experiencing stock declines despite heavy capex investments in AI. The email promotes a replay of an AI breakthrough presentation and discusses cybersecurity as a double-edged sword opportunity created by advanced AI systems.
- Read full email2026-10-29EDITORIALThe Bleeding EdgeDark Money Against TokenizationBen Lilly analyzes how dark money networks influence policy, using a recent Wall Street Journal full-page ad opposing tokenization of securities as a case study. The ad, paid by undisclosed interests, presents misleading claims about tokenized assets trading on unregulated venues, contradicting the SEC's September 17 innovation exemption that explicitly regulates these platforms.
- Read full email2026-10-28EDITORIALThe Bleeding EdgeThe AI Winter That Isn'tJason Bodner argues that AI stock weakness does not indicate weakness in AI demand, drawing parallels to crypto winter cycles. He contends that agentic AI will drive exponential compute demand despite falling per-token costs, similar to how cheaper cloud computing historically increased total spending rather than decreasing it.
- Read full email2026-10-27EDITORIALThe Bleeding EdgeWhy I’m Skipping the Anthropic IPOJeff Brown analyzes Anthropic's IPO filing (ticker: ANT), expected to be the largest IPO in history at $1.5-2 trillion valuation, raising $75-100+ billion. He explains why retail investors may want to skip this headline IPO and positions a related AI Super Chip opportunity with 1,000% upside potential.
- Read full email2026-10-26EDITORIALThe Bleeding EdgeMercury → GoldJeff Brown analyzes the economics of nuclear fusion reactors used for both energy production and mercury-to-gold transmutation, examining historical alchemy attempts and recent particle physics breakthroughs at CERN. The email promotes an upcoming AI Super Chip event while exploring how fusion companies may have cracked the economics of elemental transmutation.
- Read full email2026-10-23EDITORIALThe Bleeding EdgeThe Largest Merger in HistoryJeff Brown reports on Tesla and SpaceX forming special committees to evaluate a potential merger, positioned as the largest corporate merger in history that would create a technology conglomerate combining AI semiconductors (Terafab), robotics (Optimus), and space infrastructure. Brown responds to subscriber question about Cerebras (CBRS) stock decline, dismissing insider selling concerns as normal post-IPO liquidity activity rather than fundamental deterioration.
- Read full email2026-10-22EDITORIALThe Bleeding EdgeWhat Wall Street Is Still Missing About TokenizationBen Lilly analyzes how Wall Street is misunderstanding tokenized assets as a viable alternative to traditional financial infrastructure, using a historical analogy of Paul Baran's packet-switching innovation that AT&T dismissed. The email includes a promotion for Jeff Brown's upcoming strategy session on an AI superchip company expected to disrupt existing AI leaders.
- Read full email2026-10-20EDITORIALThe Bleeding EdgeOpportunity in the Photonics BottleneckJason Bodner analyzes photonics as a critical but underestimated AI infrastructure opportunity, arguing that as AI processors accelerate, the data communication bottleneck between systems becomes the limiting factor. The email positions optical networking components as essential infrastructure plays within the broader AI megatrend.